Video Experimental Relacionado
Updated: Sep 9, 2025
09:06
Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
Published on: November 11, 2021
2.7K
Aliança AMARTE: una red de colaboración para mejorar la atención pediátrica oncológica en Brasil
Luiz Fernando Lopes1,2, Patrícia Loggetto2, André de Oliveira Junior1
1Hospital De Câncer Infantojuvenil De Barretos, Barretos, São Paulo, Brazil.
Pediatric blood & cancer
|September 4, 2025
Resumen
La Alianza AMARTE mejoró la atención pediátrica del cáncer en Brasil a través de la colaboración. Esta red mejoró el diagnóstico, el tratamiento y la investigación, a pesar de los desafíos en la participación y la gobernanza sostenibles.
Área de la Ciencia:
- Oncología pediátrica
- Equidad en salud
- Las redes de colaboración
Sus antecedentes:
- En Brasil existen importantes disparidades regionales en el acceso al tratamiento del cáncer infantil y en la supervivencia.
- Iniciada en 2014 con seis hospitales, la Alianza AMARTE se expandió a 31 instituciones para el año 2024.
- La alianza tiene como objetivo mejorar la calidad de la atención oncológica pediátrica en todo el país.
Objetivo del estudio:
- Establecer una red de colaboración para la atención oncológica pediátrica en Brasil.
- Abordar las desigualdades en el diagnóstico y el tratamiento entre regiones geográficas.
- Fomentar la innovación, la investigación y la formación especializada en el cuidado del cáncer pediátrico.
Principales métodos:
- La Alianza AMARTE opera en cuatro pilares: igualar los diagnósticos, estandarizar el tratamiento, realizar estudios de supervivencia y promover el desarrollo científico.
- La infraestructura y los recursos humanos son apoyados por la Fundación Pío XII y el Hospital de Investigación Infantil St. Jude.
- Una evaluación semestral (SCORE) monitorea el progreso y el compromiso de los miembros utilizando indicadores definidos.
Principales resultados:
- Tres informes de participación muestran progresos, con 17 hospitales mejorando su puntuación.
- Los logros clave incluyen un registro de datos compartido, protocolos estandarizados, reuniones científicas regulares y un grupo dedicado a la recaudación de fondos.
- La alianza ha fomentado un entorno de colaboración para la innovación y el aprendizaje.
Conclusiones:
- La Alianza AMARTE demuestra el papel crítico de la colaboración en el avance de la oncología pediátrica.
- Sigue habiendo desafíos para garantizar la participación sostenida de especialistas y navegar por diversas estructuras de gobernanza.
- El desarrollo de indicadores de resultados es crucial para evaluar el impacto a largo plazo de la alianza.
Más Videos Relacionados
11:18Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
Published on: January 22, 2011
16.2K
07:39Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
Published on: November 17, 2021
3.6K
Videos de Conceptos Relacionados
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:29Chronic Pancreatitis II: Collaborative Care
128
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
128
01:27Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
01:28Chronic Kidney Disease III: Interprofessional Care
77
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
77